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Dual Diagnoses
The past two decades have seen the discovery of a
large group of Americans with co-occurring mental
illness and substance abuse problems. Commonly called
the “dually diagnosed” or those with “dual disorders,”
they are estimated to total as many as 10 million individuals in any 12-month period.1
This population seems to have emerged at least in
part as an unintended consequence of deinstitutionalization, which has exposed individuals who might previously have been sequestered in institutional settings to
the stresses and risk factors of living in the community—including the widespread availability of alcohol
and illicit drugs. While most would concur that
deinstitutionalization has on balance been beneficial for
the majority of people with mental illness insofar as it
has led to more appropriate treatment, more normal
living conditions, and less unnecessary restriction of
their rights, it has not come without its offsetting costs.
In addition, social and economic developments (such as
the growth in the number of single-parent families,
increased poverty among children, and the decreased
availability of skilled and semiskilled jobs) seem to
have contributed to increased comorbidity of mental
illness and substance abuse.
Policymakers at all levels of government have many
reasons to be interested in the dually diagnosed. This
population is prone to homelessness and/or incarceration. Public authorities have historically protected
juveniles, a group at special risk of developing dual
disorders. And the dually diagnosed constitute a multiproblem population whose needs do not fit neatly into
the categories or the service jurisdictions of most public
and private agencies.
Even more compelling for policymakers is what has
been discovered about the sequencing of mental illness
and substance abuse in most of the dually diagnosed
population. Typically, the mental illness sets in several
years before the substance use disorder, and there is
some evidence that substance abuse may constitute an
attempt to relieve the pain and anxiety caused by mental
illness through “self-medication.” In 1990, this evidence
led Darrel Regier, M.D., director of the National Institute of Mental Health’s Division of Epidemiology and
Services Research, and his colleagues to conclude the
following:
Mental disorders must be addressed as a central part
of substance abuse prevention efforts in this country. . . . The early recognition and treatment of mental

disorders is a promising primary prevention strategy
for substance abuse that awaits empirical testing.2

Especially meaningful is evidence about the age of
onset for the two disorders in the dually diagnosed
population. The median age for the development of
mental illness is 11, while the substance abuse diagnosis typically follows five to ten years later. This evidence seems to point to a “window of opportunity” for
intervention in the lives of mentally ill adolescents. If
their mental illness is diagnosed and treated sufficiently
early, they may be prevented from becoming involved
with either alcohol or other drugs, which, in turn, may
also prevent exacerbation of their mental disorder.
There are, however, considerable barriers to effective intervention. In most states, funding for mental
health services for children and adolescents is extremely
limited, as chronic, seriously mentally ill patients,
primarily adults, have become the priority population.
Despite the enactment of the Mental Health Parity Act
of 1996, which became effective January 1, 1998,
stringent visit and day limits persist in most private
insurance coverage for mental health. Managed care,
with its emphasis on “medical necessity” criteria, also
works to limit the availability of behavioral health care
services. Problems caused by these basic funding
barriers are further complicated by the well-documented
failure of many primary care physicians to diagnose
mental illness and substance abuse and the tendency of
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even many mental health and substance abuse professionals to overlook co-occurring disorders.
For the population with “full-blown” co-occurring
mental and substance use disorders, the obstacles seem
only steeper. The mental health and substance abuse
professions operate from disparate treatment paradigms.
Few programs exist that offer integrated treatment for
co-occurring disorders. Frequently, mental health
programs tend to exclude those with active substance
use disorders, and alcoholism and substance abuse
programs tend to deny access to those with mental
illness. As Robert Drake, M.D., of the New HampshireDartmouth Psychiatric Research Center, and his colleagues recently described the situation:
With conceptualization of the dual-diagnosis problem
came a clearer picture of the poor fit between dually
diagnosed patients and the existing treatment system.
Mental health and substance abuse services were
provided in separate, parallel treatment streams that
demonstrated little capacity to modify their programs
and to cooperate with one another to individualize
services for those with dual disorders. As far as each
stream was concerned, the dually diagnosed patient
had one disorder too many [emphasis added].3

This Forum session coincides with the expected
release of a report on co-occurring disorders by the
National Advisory Council of the Substance Abuse and
Mental Health Services Administration (SAMHSA) of
the U.S. Department of Health and Human Services
(DHHS).4 It marks a propitious time to examine public
policy affecting those with dual mental illness and
substance abuse. The Forum meeting will review what
is known about the this population, the phenomenon of
comorbidity, and diagnosis and treatment of those with
concurrent disorders. Attendant problems of homelessness and involvement with the criminal justice system
will also be examined. Factors which have contributed
to the co-occurrence of mental illness and substance
abuse will be identified, as will professional and organizational barriers to accurate diagnosis and integrated
treatment.
Finally, public policy implications of comorbidity
will be discussed. The phenomenon of co-occurring
mental and substance use disorders is an impediment to
workforce participation—an important consideration in
welfare reform, given the disproportionate concentration of the dually diagnosed in the poverty population.
The evidence about the “window of opportunity” for
intervention in the lives of adolescents has implications
for states as they choose who is to be covered and what
services are to be offered under the new State Child
Health Insurance Program enacted as part of the Bal-

anced Budget Act of 1997. The likelihood that many
patients served under state managed behavioral health
care initiatives will have dual disorders should help
shape decisions about how mental health and substance
abuse services are to be carved out. Because so many
dually diagnosed patients become involved in crime,
intervening with timely treatment might also be seen as
a crime prevention strategy.

BACKGROUND
Data from Major Surveys
Most current data on the dually diagnosed population derive from two surveys conducted and analyzed
over the past two decades—the Epidemiologic Catchment Area (ECA) Survey, the first wave of which was
administered from 1980 to 1984,5 and the National
Comorbidity Survey (NCS), administered between 1990
and 1992.6 Each explored the phenomenon of
comorbidity among the general population. While the
two surveys yielded somewhat different findings on the
prevalence of specific mental disorders—which is not
surprising since (among other differences) the ECA was
focused on five geographic areas while the NCS had
respondents in 34 states—they yielded remarkably
consistent findings about comorbidity.
Each survey’s sample was limited to nonaged adults
and those in their later teens. (The ECA’s population
was limited to those 18 to 64, while the NCS survey
was restricted to those 15 to 54.) The NCS was a
household survey in the strictest sense of the word; only
the ECA dealt with institutionalized and homeless
individuals. Except as noted, however, the data in this
issue brief are from the NCS, the more recent of the two
surveys and the one based on a more representative
national sample.
To begin with, the NCS found that psychiatric
disorders of all kinds are more prevalent than previously
believed; 48 percent of respondents reported a lifetime
history of at least one disorder, and 29 percent indicated
at least one disorder within the past 12 months. (A
lifetime disorder is defined as one present at least once
during the course of a person's life.) While the presence
of a disorder does not necessarily connote major disability or impairment of daily functioning, the NCS finding
does indicate that a sizable portion of the population
have experienced some level of mental illness.
According to the NCS, the most common disorders
are major depression and alcohol dependence, reportedly experienced on a lifetime basis by 17.1 percent and
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14.1 percent of the population, respectively. Next most
common are social and simple phobias (13.3 percent
and 11.3 percent). Collectively, substance abuse and
anxiety disorders (including phobias) are somewhat
more common than affective disorders (such as depression). Those reporting any lifetime substance abuse or
dependence constituted 26.6 percent of the population,
those with anxiety disorders 24.9 percent, and those
with affective disorders 19.3 percent.
With respect to comorbidity—the co-occurrence of
more than one disorder, not necessarily limited to
mental illness and alcohol or drug disorders—56
percent of those with any disorders had two or more. Of
these, 27 percent had only two disorders, while 29
percent had three or more. Total disorders were heavily
concentrated—over half of all disorders found among
those surveyed were concentrated in the group with
three or more disorders, which constituted 14 percent of
the total survey population. Extrapolated to the population as a whole, these findings mean that three million
people with co-occurring disorders have at least three
disorders, and one million have four or more.
Turning specifically to co-occurring mental illness
and substance use disorders, 52 percent of those with
lifetime alcohol abuse or dependence also had a lifetime
mental disorder. (Thirty-six percent also had a lifetime
nonalcohol drug use disorder.) Of those with a lifetime
history of drug abuse or dependence, 59 percent had a
lifetime mental disorder. (Seventy-one percent also had
a lifetime alcohol use disorder.) Viewed from another
angle, the NCS and other studies indicate that people
with mental disorders are at least twice as likely to
abuse alcohol and other drugs as people with no mental
disorder. In other words, those with mental illness or
substance use disorders are at high risk of co-occurring
disorders that bring them into the dually diagnosed
population.
Regier, who is a leader in the development and
interpretation of the ECA, and his colleagues placed
these relationships in a broader epidemiological context,
which helps explain the interrelationships at work here:
Since in the general population mental disorders are
more prevalent than alcohol disorders, which in turn
are more prevalent than other drug disorders, there is
a natural statistical tendency for the rates of co-occurring disorders to be higher in alcohol treatment than in
mental health treatment settings, and highest in other
drug abuse patient populations.7

Because the assessments of substance abuse are based
on self-reporting, and the tendency to underreport

substance abuse is significant, both the NCS and ECA
may tend to underestimate both the extent of substance
abuse and its co-occurrence with mental illness.
The NCS indicates that comorbid psychiatric orders
are both more severe and more chronic than purely
psychiatric disorders. Nonetheless, only a minority of
those with co-occurring disorders are in treatment.
(Partly because they are so seriously ill, however, they
are more likely to get treatment than those who experience only one disorder within a 12-month period.) Even
among the group with three or more disorders, only half
are receiving any kind of treatment. Furthermore, most
of those in treatment are receiving only general medical
attention, not specialized mental health or substance
abuse treatment.
As noted above, the NCS also seems to indicate a
significant sequencing in the comorbidity of mental
illness and substance use disorders. For almost 90
percent of NCS respondents with such comorbidity, the
mental disorder develops first. Furthermore, for the vast
majority of dually diagnosed individuals, the mental
illness sets in during their adolescent years. Typically,
the subsequent addictive disorder develops within five
to ten years. Median age of onset for the mental illness
is 11, while the median age of subsequent onset for an
addictive disorder is 21. This period represents the
“window of opportunity” for preventive intervention
noted above. Obviously, the size of the window varies
with the individual.

Comorbidity, Causality, and Relapse
The fact that co-occurring substance use disorders
typically follow the onset of mental disorders should
not be interpreted to connote a causal relationship. As
Ronald Kessler, Harvard professor of health care policy
and coordinator of the NCS, and his colleagues cautioned in a recent article: “It is important to recognize
that neither temporal order nor prediction can be taken
to imply causal priority.”8 Ultimately, only longitudinal
surveys can confirm or disprove causality, and they
have not yet been undertaken.
In the National Advisory Council report to
SAMHSA, it is noted that at least four relationships are
possible between co-occurring disorders:





One may directly cause the other.
One may indirectly lead to the other (for example,
through self-medication).
They may develop from different causes, but interact
with each other.

5



A common, independent factor (such as childhood
emotional trauma) may cause both.

While more research is needed to determine the
causal relationship between co-occurring mental and
substance use disorders, there seems to be sufficiently
strong evidence to indicate the importance of mental
health intervention as a strategy to prevent subsequent
onset of substance dependence or abuse and to reduce
the likelihood that the underlying mental illness will be
worsened by concurrent substance use disorders. The
importance of preventive intervention seems especially
clear for the adolescent population.
Research has shown that dually diagnosed people
have a tendency to relapse. Drake and colleagues have
pointed out: “Severely mentally ill patients followed in
the community for one year had higher rates of
rehospitalization if they were dually diagnosed. Substance abuse tends to persist among those with severe
mental illness.” Similarly, the SAMHSA National
Advisory Council report on comorbidity underscores
the risk of relapse in this population:
The most common cause of psychiatric relapse today
[in the dually diagnosed population] is the use of
alcohol, marijuana, and cocaine. The most common
cause of relapse to substance use/abuse today is
untreated psychiatric disorder.

Given these relationships, appropriate, timely treatment
of comorbid conditions can also be regarded as a form
of secondary prevention.
Any discussion of the seemingly recent comorbidity
phenomenon would be incomplete without Kessler's
cautionary note that it may in part actually reflect the
increasing sophistication of the diagnostic tools available to clinicians:
Although a number of recent studies...have been
consistent with the NCS in showing that there is
substantial lifetime and episode comorbidity among
psychiatric disorders, controversy exists concerning
the extent to which these results are, at least in part,
artifacts of the recently developed diagnostic systems
used to operationalize psychiatric disorders. . . . These
systems . . . dramatically increased the number of
diagnostic categories and reduced the number of
exclusion criteria, resulting in the assignment of
multiple diagnoses to many people who would previously have received only a single diagnosis.9

The Diagnostic and Statistical Manual of Mental
Disorders (DSM), the diagnostic gold standard published by the American Psychiatric Association, has
undergone two major revisions in the past two decades.

What are now considered co-occurring disorders may
have been lumped together under common diagnostic
categories in the not-too-distant past. This point is not
meant to minimize the importance of co-occurrence, but
to assist in explaining this phenomenon, especially in a
historical context.

Dual Diagnoses, Homelessness, and Crime
Not surprisingly, having co-occurring mental and
substance use disorders places an individual at greater
jeopardy of a marginal social existence. Kessler has
identified the following proximate risk factors associated with general comorbidity of any type included in
the NCS:
Among the social role impairments significantly
associated with comorbidity are marital separation and
divorce, social isolation, and exposure to conflictual
social relationships. Among the work role impairments significantly associated with comorbidity are
low educational attainment, unemployment, and
chronic financial difficulties.10

Longer-term risk factors include poverty, homelessness,
crime and incarceration, and exposure to and involvement in violence. All of these factors may further
compromise access to needed treatment. Their implications for the nation’s current welfare reform efforts
seem clear; dual disorders constitute a significant
obstacle to moving poor people from welfare to work.
It is estimated that between 10 and 20 percent of the
homeless population have co-occurring severe mental
illness and substance use disorders. Typically, they have
had a history of mental illness and/or substance abuse
problems since they were children. Their very homelessness often reflects the failure of the treatment
system to address their dual disorders. As Robert Drake
and Kim Mueser of the New Hampshire-Dartmouth
Psychiatric Research Center recently observed:
Patients with dual diagnoses of severe mental illness
and AUD [alcohol use disorder] are particularly prone
to unstable housing arrangements and homelessness. . . . One reason for this increased risk appears to
be that dually diagnosed clients often are excluded
from housing and treatment programs designated
specifically for people with single disorders. . . . Compared with other homeless subgroups,
those with co-occurring severe mental illness and
AUD are more likely to experience harsh living
conditions, such as living on the streets rather than in
shelters; suffer from psychological distress and demoralization; grant sexual favors for food and money; be
picked up by the police; become incarcerated; be
isolated from their families; and be victimized.11
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Given the transience of dually diagnosed homeless
people, their poor access to health care of any kind, and
their inability to afford public transportation, experts in
the field maintain that it is especially important for this
population to be able to use mental health and substance
abuse services which are at least provided in the same
location—if not fully integrated.
On March 5, 1998, the front page of the New York
Times featured an article by Fox Butterfield entitled,
“Prisons Replace Hospitals for the Nation’s Mentally
Ill.” The reporter described the Los Angeles County Jail
as “by default . . . the nation’s largest mental institution
. . . [with] 1,500 to 1,700 inmates who are severely
mentally ill, most of them detained on minor charges,
essentially for being public nuisances.”
This is the latest evidence of a phenomenon described by Bert Pepper, M.D., and Hilary Ryglewicz in
the following terms: “As psychiatric beds have decreased, prison beds have increased, and the problem of
social control of mentally ill people has thereby been
transferred to the criminal justice system by transinstitutionalization.”12 The number of public psychiatric
beds in the country (primarily in state and county
mental hospitals) dropped from 559,000 in 1955 to
69,000 in 1995, largely as a result of deinstitutionalization. Over the past 25 years, the nation has greatly
expanded its prison and jail capacity; the number of
those incarcerated has jumped about tenfold—from
200,000 in 1972 to an estimated 2 million in 1995.
The population of the country has grown by 100
million in the past 40 years. Thus, the number of public
psychiatric beds per 1,000 population has declined
sharply, while the number of prison beds per 1,000 has
soared. As one system has expanded, the other has
shrunk. New York, a state with only 5,800 adult patients
in its public mental hospitals, has an estimated 6,000
state prison inmates with serious mental disorders.
Butterfield’s article adds the following perspective:
With voters willing to spend freely to fight rising
crime rates, states were building more jails and
prisons. Jails became the only institutions left open to
the mentally ill 24 hours a day. . . . In many states, so
many public hospitals have closed, or the laws regulating admission to hospitals have been made so tight,
that sometimes the only way to get care is to be
arrested. Resources are especially scarce for juveniles.

All of this has occurred against a backdrop of tougher
law enforcement intervention against the use and sale of
illicit drugs.

Each of these developments has important implications for the dually diagnosed population. Any direct
personal involvement with illicit drugs is by definition
criminal activity. Further, by causing a decrease in
social and functional status, co-occurring mental and
substance use disorders may predispose some individuals to crime. It is estimated that more than one million
prisoners in the United States—over half of the incarcerated population—have dual mental illness and
substance use disorders. 13 In light of this, effective
diagnosis and treatment of dual disorders can be seen as
a crime prevention as well as a public health strategy.
Providing effective treatment to prison and jail
inmates with dual disorders would seem to make sense,
if for no other reason than that most will eventually
return to the community and the likelihood of their
recidivism without treatment is high. Yet the lack of
any behavioral health treatment for most of the nation’s
incarcerated population—much less integrated treatment for dually diagnosed inmates—has been well
documented. For example, the Center for Substance
Abuse Treatment has reported: “Less than 10 percent of
Federal inmates who are addicted have treatment
available to them, despite the fact that research over the
past decade confirms that intensive prison treatment
programs can reduce recidivism by half after release.”14

Factors Contributing to
Increased Comorbidity
Over the past several decades, a number of social
and economic developments have combined to create
an environment that seems to have increased people’s
susceptibility to the co-occurrence of mental illness and
substance abuse. These phenomena include the growth
in single-parent families, the increase in poverty among
children, the decline in the number of unskilled and
semi-skilled jobs, and the greater availability and
acceptability of illicit drugs such as marijuana and
cocaine.
The growth of the “drug culture” has had a profound
impact on the expansion of this population, especially in
a context where people who might formerly have been
institutionalized now remain in the community. Youth
exposure to drugs has been on the rise for some time
now. In 1962, only 2 percent of those over 12 years old
had ever used an illicit drug. By two decades later,
almost half the adult population had at least experimented with an illicit substance. The age of first drug
use is steadily declining to the point where even elementary school children need to be educated about drugs.15
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Further complicating the situation is the frequency
with which dual disorders go undetected by general
practitioners as well as mental health and substance
abuse specialists. When the co-occurring disorders are
not detected, clinicians tend to provide inadequate or
inappropriate treatment, further exacerbating the patient’s condition. Drake and colleagues have described
this tendency in mental health programs as follows:
Several factors account for the high rates of nondetection, including mental health clinicians’ inattention to
AOD [alcohol and other drug] abuse; patients’ denial,
minimization, or inability to perceive the relationships
between AOD use and their medical and social problems; and the lack of reliable and valid detection
methods for this population. Failure to detect AOD
abuse in psychiatric settings can result in misdiagnosis; overtreatment of psychiatric syndromes with
medications; neglect of appropriate interventions, such
as detoxification, AOD education, and AOD abuse
counseling; and inappropriate treatment planning.

One study gives particularly striking evidence of
how insidiously factors conspire to inhibit the diagnosis
of co-occurring disorders. Fifty-six consecutive people
admitted to a psychiatric hospital were tracked, of
whom 62 percent had positive urine tests for at least one
abused drug. Admitting physicians failed to detect drug
use in 66 percent of those with positive urinalyses—
frequently because they credited patient denials of drug
involvement. Of the 26 patients with positive test results
who denied their recent drug use, only one received a
positive assessment for drugs by admitting physicians.16
Reformers have called for more aggressive diagnostic techniques to detect co-occurring disorders. In
particular, they have recommended that clinicians
routinely consider the possibility that patients presenting with either mental illness or substance abuse might
have a co-occurring disorder.

IMPROVING TREATMENT
Few dually diagnosed patients are able to receive
integrated treatment from a single provider or provider
group. As a result, they are often at the mercy of
separate systems that are ill-suited to treating people
with more than a single disorder. Moreover, they are
often subject to the conflicting directions of mental
health and substance abuse clinicians. Abstinence from
all drugs—even psychotropic medications which are the
basis of most modern psychiatric treatment regimens—is typically demanded by most substance abuse
programs. On the other hand, many mental health
programs are unwilling to accept patients with a history
of alcoholism and/or drug abuse. Left to the mercies of

these very disparate systems, it is no wonder that many
dually diagnosed patients fall through the cracks.
The report of the SAMHSA National Advisory
Council captures their dilemma well:
For those who have had treatment for both their
substance-related and their mental disorder, most have
had to go to two offices or agencies, and been sent
back and forth: “We’ll help you with your depression
when you’ve been sober for six months.” Or, “We’ll
be happy to enroll you in our alcoholism counseling
program when you have had six months free of
suicide attempts and are off medication.”

Most experts concur that only integrated treatment
will ultimately prove cost-effective in the treatment of
those with co-occurring mental and substance use disorders. The SAMHSA Advisory Council report suggests the following definition of integrated treatment:
“the simultaneous treatment of all disorders by an
appropriately dually-trained clinician, or a unified treatment team whose members are competent to treat both
the substance-related and the mental health disorders.”
Integration of treatment seems to promise reduced
hospitalization and concomitant expenses, decreased
substance abuse and more rapid recovery, and other
basic improvements in quality of patient life, such as
improved residential stability. Yet, as documented in a
1995 report issued by DHHS Office of Inspector
General, such programs are quite rare: “Few receive
integrated treatment in a single setting, yet without it,
response to treatment is likely to be poor.”17 More
typically, the burden of integrating treatment falls on
individual patients themselves, who are shunted between programs with quite disparate treatment philosophies and bear the costs of trying to make sense of their
often conflicting directions.
Both professional and organizational rivalries and
jealousies often conspire to add to the difficulties faced
by individuals with dual disorders. Mental health
professionals are typically trained in the disciplines of
psychiatry, psychology, or social work, while substance
abuse counselors are often former substance abusers
themselves, and their training is based on the experience
and self-help philosophy of Alcoholics Anonymous
and/or Narcotics Anonymous. Most professionals in
each field have been trained to work only with individuals having a single disorder; reformers underscore the
need for cross-training of professionals in each field to
improve services to patients with dual diagnoses.
Moreover, state mental health and substance abuse
agencies are usually autonomous from each other and
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often fall victim to turf wars. Even when placed within
the same “umbrella” human services agency, their
programs and policies are often poorly coordinated.
Some states, such as California, have made signal
progress in overcoming bureaucratic inertia, categorical
funding constraints, and other obstacles to integrated
programming for the dually diagnosed.

THE FORUM SESSION
The report on co-occurring disorders by the
SAMHSA National Advisory Council suggests the
following national strategy:
To improve prevention, treatment, and rehabilitation
services for the several million individuals with, or at
risk of developing, co-occurring substance-related and
mental health disorders. . . . By providing guidance
toward specific outcome domains, such as reduced
drug use, increased mental health stability, greater
housing stability, improved health status, less involvement in the juvenile and adult criminal justice system,
a higher quality of life, and higher rates of employment, implementation of the national strategy will be
of maximum value to the nation.

The Forum session will examine the political feasibility of this strategy in the context of the many barriers
to integrated treatment, including professional and
organizational rivalries and the seeming intractability of
professional practice to government influence. The role
of SAMHSA and state mental health and substance
abuse agencies as catalysts for change will also be
discussed.
Among the issues to be considered are the following:








What are the major gaps in our knowledge base
about those with co-occurring mental illness and
substance abuse? Can government and foundations
jointly underwrite the necessary research to address
these questions? Do additional data bases besides
the NCS and ECA need to be developed?
What can be done to assure that dual disorders are
better identified and diagnosed?
How can people with mental disorders—especially
adolescents—be prevented from developing substance abuse disorders?
What sort of intervention should be made to address
the needs of the sizable number of prison and jail
inmates with co-occurring disorders?
What strategies should be pursued to meet the
treatment needs of homeless people with dual
disorders?








What are the pros and cons of single-purpose public
substance abuse and mental health agencies? Of
funding programs restricted to mental health or
substance abuse services?
What role can and should government play in
fostering integrated treatment? What can government do to reduce the professional and organizational barriers to integration?
Should the current SAMHSA mental health and
substance abuse block grants allow for commingling
of funds for programs for those with co-occurring
mental health and substance abuse services?
Should the organization of SAMHSA take more
formal recognition of the phenomenon of co-occurring disorders? Can the Office of the Administrator
effectively mobilize the resources and coordinate the
programs of the separate Centers for Mental Health
Services, Substance Abuse Treatment, and Substance Abuse Prevention to address the needs of the
dually diagnosed?

Speakers
Bert Pepper, M.D., executive director of the
Information Exchange, Inc., in New City, New York,
will begin the meeting with an overview of co-occurring mental illness and substance abuse disorders. He
will also present the findings included in the SAMHSA
National Advisory Council report, which he wrote. Dr.
Pepper has been director of the Consultation Service of
the American Psychiatric Association since 1984 and
has engaged in the private practice of psychiatry since
1962. From 1975 to 1988, he served as director of the
Rockland County (New York) Mental Health Center
and commissioner of community services. Prior to that,
he served for three years as Maryland state commissioner of mental hygiene and for four years as associate
commissioner of the New York State Department of
Mental Hygiene. Dr. Pepper received his medical
education at the New York University School of
Medicine, served his internship at the U.S. Public
Health Service Hospital in Staten Island, and completed
his psychiatric residency at New York State Psychiatric
Institute and Rockland State Hospital, where he also
served as senior psychiatrist.
Darren Skinner, M.S.W., C.S.W., C.A.S.A.C.,
social worker and chemical dependency counselor at
Staten Island University Hospital, will follow and tell
about his personal experience working with and living
among people who are dually diagnosed. He will also
describe the unique program of Harbor House, which
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provides integrated services to dually diagnosed homeless people. Mr. Skinner has over eight years of experience in the field of mental health and substance abuse
treatment and serves as an independent training consultant with the Information Exchange, Inc. An adjunct
professor at Audrey Cohen College in New York City,
he received the 1995 Certified Addiction Counselor of
the Year Award for the New York City region.
Next, Arthur Cox, D.S.W., L.C.S.W., program
director of the Florida Center for Addictions and Dual
Disorders, will describe his 50-bed residential treatment
program for people with co-occurring mental illness
and substance abuse disorders. He will focus on what it
means to provide integrated treatment as well as the
cost-effectiveness of such treatment. Dr. Cox is also
CEO of the Mid-Florida Center for Mental Health and
Substance Abuse Services, Inc., a consulting organization specializing in dual disorders. Previously, he
served as superintendent of Florida’s first and only
JCAHO-accredited mental health institution, the Florida
Addictions Treatment Center. He has also served as
interim superintendent of a mental health center in
Boston and as dean of two schools of social work. Dr.
Cox received his D.S.W. from Columbia University.
Stephen Mayberg, Ph.D., director of the California
Department of Mental Health, will follow with a
description of the challenges he faces as director of the
largest state mental health agency in the nation in
serving dually diagnosed patients and the steps California has taken to provide innovative services in this area.
He will also tell about his recent experience negotiating
with SAMHSA to secure approval to fund integrated
services to dually diagnosed patients from the separate
federal mental health and substance abuse block grants.
Appointed to his current position in February 1993, Dr.
Mayberg has responsibility for a budget of almost $2
billion as well as nearly 7,500 employees. Previously,
he served as director of the Yolo County Mental Health
program. Throughout his public service career, he has
continued to provide clinical services. Dr. Mayberg
received his doctorate in clinical psychology from the
University of Minnesota, completed his internship at the
University of California, Davis, and has worked in the
California mental health system since that time.
Kevin Hennessy, Ph.D., health policy analyst in the
Office of the Assistant Secretary for Planning and
Evaluation (ASPE), DHHS, will conclude with a
discussion of the public policy issues that arise from
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